History
2026: Participation in the medical cartel for 4.6 billion rubles
On January 16, 2026, the Federal Antimonopoly Service (FAS) of Russia opened a case of cartel conspiracy on the supply of medical goods for state institutions of the Voronezh region in the amount of 4.6 billion rubles. This was reported by the press service of the FAS Russia Office for the Voronezh Region.
The list of defendants in the case includes five companies specializing in the wholesale trade in pharmaceutical products: Diafarm, Pharm-Group, Aibolit 36, M-Complimed and SV-Pharm 36. The Antimonopoly Service believes that they acted in concert, artificially limiting competition in procurement.
According to SPARK-Interfax, in 2021, 15 cases of joint participation of Diafarm and Farm Group in the procurement of critical drugs, such as antitumor doxorubicin and the antibiotic ampicillin with sulbactam, were recorded. One intersection was found between Diafarm and Aibolit 36 when purchasing the drug perindopril for the Liskinskaya district hospital.
The largest among the defendants is Diafarm (director - Alexander Litvin, beneficiary - Svetlana Budnikova) with revenue of 938.2 million rubles. at the end of 2024. Pharm Group (director and beneficiary - Vladimir Budnikov) earned 330.8 million rubles. The revenue of the remaining companies was: M-Complimed (director - Alla Semischastnova) - 163.6 million rubles, SV-Pharm 36 (director - Maxim Semischastnov) - 187.6 million rubles, Aibolit 36 (director - Nikolai Yuriev) - 55.5 million rubles.
In case of evidence of an offense, participants in the Voronezh cartel face large negotiable fines, a review of the procurement results and a possible transfer of materials to law enforcement agencies.
According to Vademecum, the FAS has already identified similar violations in the field of public procurement of medicines. In October 2025, the department recognized the participants in the conspiracy of IFC "Arfa" and "Expanses of Health." At the end of 2025, a case was initiated on the facts of collusion in 114 procurement procedures for medical institutions in Moscow for almost 277 million rubles.[1][2]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |